Literature DB >> 18246521

Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases.

Ekaterina Dadachova1, Arturo Casadevall.   

Abstract

There is a renewed interest in antibody-based therapy for infectious diseases. Antibodies armed with different cytotoxic agents such as toxins, drugs or radionuclides can specifically target virally infected host cells or microbes themselves, thus potentially providing new options for the treatment of infectious diseases. The technologies for arming antibodies with different cytotoxic agents are well advanced. Overall, armed antibody therapy provides an exciting new strategy that may potentially be useful against a variety of infectious diseases and tumors caused by microbial agents. This review highlights the use of armed antibodies to target infected host cells or to target the microbes themselves, describing challenges and future directions for both approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18246521

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  5 in total

1.  Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells.

Authors:  Ruth A Bryan; Zewei Jiang; Xianchun Huang; Alfred Morgenstern; Frank Bruchertseifer; Rani Sellers; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

Review 2.  Cancer radioimmunotherapy.

Authors:  Robert M Sharkey; David M Goldenberg
Journal:  Immunotherapy       Date:  2011-03       Impact factor: 4.196

Review 3.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

4.  Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs.

Authors:  Edward A Berger; Ira Pastan
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

Review 5.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.